Non Hepatosplenic Extramedullary Manifestations of Chronic Myelomonocytic Leukemia: Clinical, Molecular and Prognostic Correlates

Ítems similars

• Nucleophosmin 1 (NPM1) Mutations in Chronic Myelomonocytic Leukemia and Their Prognostic Relevance
  per: Vallapureddy, Rangit, et al.
  Publicat: (2017)
• EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental
  per: Patnaik, Mrinal M., et al.
  Publicat: (2018)
• Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
  per: Lasho, Terra L., et al.
  Publicat: (2018)
• A prospective evaluation of vitamin B1 (thiamine) level in myeloproliferative neoplasms: clinical correlations and impact of JAK2 inhibitor therapy
  per: Gangat, Naseema, et al.
  Publicat: (2019)
• Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of 39 patients
  per: Pophali, Prateek, et al.
  Publicat: (2018)